Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Bolsa de valores de Sao Paulo  >  Fleury SA    FLRY3   BRFLRYACNOR5

FLEURY SA (FLRY3)

End-of-day quote. End-of-day quote  - 05/27
58.22 BRL   --.--%
04/10 NOTICE TO THE M : change in management
03/10 FLEURY : Payment of dividends
2016 FLEURY : Payment of Dividends and Interest on Shareholders’ Eq..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
The feature you requested does not exist. However, we suggest the following feature:

Notice to the market: change in management

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/10/2017 | 03:25pm CEST

FLEURY S.A.

Public Company

CNPJ nº 60.840.055/0001-31 NIRE nº 35.300.197.534

Change in Management São Paulo, April 10, 2017 - In order to update its shareholders and the market in general, Fleury S.A. ("Company") hereby informs that ADOLPHO CYRIACO NUNES DE SOUZA NETO has left the position of Chief Financial Officer and Investor Relations Officer on this date. The Company is grateful to Adolpho Souza Neto for his numerous contributions to the progress we have made in our organization.

The Company also announces the appointment and approval by the Board of Director of FERNANDO AUGUSTO RODRIGUES LEÃO FILHO, for the position of Chief Financial Officer, and VIVIANE BEHAR DE CASTRO, for the position of Investor Relations Officer.

A brief profile of the two new executives of the Company can be accessed on our website: http://ri.fleury.com.br.

CARLOS ALBERTO IWATA MARINELLI Chief Executive Officer

Fleury SA published this content on 10 April 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 10 April 2017 13:25:06 UTC.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FLEURY SA
04/10 NOTICE TO THE MARKET : change in management
03/10 FLEURY : Payment of dividends
2016 FLEURY : Payment of Dividends and Interest on Shareholders’ Equity
2016 FLEURY : Grupo Fleury announces its 3Q16 results schedule and quiet period
2016 NOTICE TO THE MARKET : reduction of ownership participation
2016 COMUNICADO AO MEFRCADO : redução de participação da Invesco
2016 FLEURY : Grupo Fleury launches the new version of the Investor Relations website
2016 FLEURY : Grupo Fleury integrates IBrX100 portfolio
2016 FLEURY : Financial Statements - 2Q16
2016 MATERIAL FACT : Stock Option Plan
More news
Sector news : Medical & Diagnostic Laboratories
05/24 FTSE edges up helped by M&S, but miners weigh
05/24 Middle East rules hurts South Africa's Mediclinic earnings
05/19DJIHH HEALTHCARE BHD : Malaysia's IHH Healthcare 1Q Net Profit Rises
05/03DJFRESENIUS : Sales, Profit Increased in 1st Quarter -- Update
05/03DJFRESENIUS : Sales, Profit Increased in 1st Quarter
More sector news : Medical & Diagnostic Laboratories
Advertisement
Financials ( BRL)
Sales 2017 2 385 M
EBIT 2017 445 M
Net income 2017 295 M
Debt 2017 355 M
Yield 2017 1,19%
P/E ratio 2017 30,07
P/E ratio 2018 24,66
EV / Sales 2017 3,99x
EV / Sales 2018 3,48x
Capitalization 9 164 M
More Financials
Chart FLEURY SA
Duration : Period :
Fleury SA Technical Analysis Chart | FLRY3 | BRFLRYACNOR5 | 4-Traders
Full-screen chart
Technical analysis trends FLEURY SA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 49,6  BRL
Spread / Average Target -15%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Carlos Alberto Iwata Marinelli Chief Executive Officer
Marcos Bosi Ferraz Chairman
Claudio Almeida Prado Executive Director-Operations Support
Adolpho Cyriaco Nune de Souza Neto Chief Finance Officer & Head-Investor Relations
Jeane Tsutsui Executive Director-Medical & Technical
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
FLEURY SA65.09%2 814
SONIC HEALTHCARE LIMIT..5.47%7 044
DR. LAL PATHLABS LTD-16.38%1 156
BML INC-20.53%875
CENTRO DE IMAGEM DIAGN..19.80%628
THYROCARE TECHNOLOGIES..2.31%593
More Results